Duprey Lauren Rusckowski
Chief Transformation Officer
SaleAlert
- Shares
- 34,535
- Price
- $18.54
- Value
- $640,279
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•83 filings
TAK
TAKEDA PHARMACEUTICAL CO LTD
Net sales of $4.4M over the last 3 months
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$4,350,264
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$4,350,264
4 distinct insiders
Highlighted alerts
5
2 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get TAK insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
TAK overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
81
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
67
Administrative noise
Stored, never alerted
2
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 14,006
- Price
- $17.10
- Footnotes
- 2
Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Plump Andrew Stewart
President, R&D
Sale 10b5-1
- Shares
- 116,191
- Price
- $18.49
- Value
- $2,148,372
Plump Andrew Stewart
President, R&D
Sale 10b5-1
- Shares
- 19,651
- Price
- $18.49
- Value
- $363,347
Greenway Nicola Deidre Petal
Chief Human Resources Officer
SaleAlert
- Shares
- 12,980
- Price
- $18.11
- Value
- $235,118
Shannon Elaine Mary
Pres., Global Supply & Quality
SaleAlert
- Shares
- 20,363
- Price
- $17.55
- Value
- $357,371
Greenway Nicola Deidre Petal
Chief Human Resources Officer
SaleAlert
- Shares
- 33,628
- Price
- $17.51
- Value
- $588,715
Greenway Nicola Deidre Petal
Chief Human Resources Officer
SaleAlert
- Shares
- 975
- Price
- $17.50
- Value
- $17,063
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Duprey Lauren Rusckowski Chief Transformation Officer | Sale | 34,535 | $18.54 | $640,279 | |
| Sep 02, 2026 | Plump Andrew Stewart President, R&D | Sale | 116,191 | $18.49 | $2,148,372 | |
| Aug 19, 2026 | Plump Andrew Stewart President, R&D | Sale | 19,651 | $18.49 | $363,347 | |
| Aug 18, 2026 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Sale | 12,980 | $18.11 | $235,118 | |
| Aug 11, 2026 | Shannon Elaine Mary Pres., Global Supply & Quality | Sale | 20,363 | $17.55 | $357,371 | |
| Aug 10, 2026 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Sale | 33,628 | $17.51 | $588,715 | |
| Aug 10, 2026 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Sale | 975 | $17.50 | $17,063 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.